CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows (used in) provided by operating activities:
Net (loss) income	$ (4,280)	$ 432
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation	3,359	2,698
Amortization of purchased intangible assets	12,976	324
Amortization of deferred debt issuance costs	132	56
Amortization of acquisition-related inventory valuation step-up	258	0
Stock-based compensation	2,358	1,608
Deferred income taxes	(2,714)	(2,334)
Loss (gain) on disposal of property, plant and equipment	9	(288)
Restructuring expenses and asset impairments	32	127
Change in:
Accounts receivable, net	(7,480)	(4,629)
Inventories	(19,877)	(6,184)
Prepaid expenses and other	(2,324)	(4,480)
Accounts payable	7,162	9,963
Contract liabilities	5,968	2,432
Accrued expenses and other liabilities	(163)	2,451
Net cash (used in) provided by operating activities	(4,584)	2,176
Cash flows (used in) provided by investing activities:
Proceeds from maturities of marketable securities	0	4,799
Acquisition of property, plant and equipment	(1,536)	(1,365)
Proceeds on sale of property, plant and equipment	0	281
Net cash (used in) provided by investing activities	(1,536)	3,715
Cash flows (used in) provided by financing activities:
Payments on term loan	(3,750)	0
Repayments on capital expenditure facility	0	(11,750)
Payment of debt issuance costs	(97)	0
Distributions to redeemable noncontrolling interest holder	(4,400)	0
Net proceeds from issuance of common stock through at-the-market offering program	0	25,262
Treasury stock purchases	(1,088)	(2,435)
Net cash (used in) provided by financing activities	(9,335)	11,077
Effects of exchange rates on cash	21	682
Net (decrease) increase in cash and cash equivalents	(15,434)	17,650
Cash and cash equivalents, beginning of the period	30,810	28,187
Cash and cash equivalents, end of the period	$ 15,376	$ 45,837